A federal judge has ordered the Biden-era green energy grants to resume, including $2 billion awarded to a group tied to Stacey Abrams. The Trump EPA had tried to cancel the program, citing waste and abuse.
Key Facts:
- Judge Tanya Chutkan ordered the EPA to restart a $20 billion green energy grant program.
- The Trump administration had terminated the program in March 2025, citing misuse and lack of oversight.
- One recipient, Power Forward Communities—linked to Stacey Abrams—was awarded $2 billion despite only $100 in 2023 revenue.
- The program’s funds were placed at Citibank, creating roadblocks to federal oversight.
- The Department of Justice and EPA Inspector General have both opened investigations into the fund’s disbursement.
The Rest of the Story: EPA Grant Program Reinstated by Judge
The Biden administration’s Greenhouse Gas Reduction Fund, authorized by the 2022 Inflation Reduction Act, distributed $20 billion in grants to eight environmental groups.
Among them was Power Forward Communities, a new nonprofit tied to Stacey Abrams, which was awarded $2 billion to electrify low-income housing despite showing minimal financial history.
After taking office, EPA Administrator Lee Zeldin shut down the program in March 2025 and requested investigations into questionable disbursements.
The grants had been managed via Citibank, a structure that reduced federal control and alarmed oversight officials.
Several groups sued in response, with Judge Tanya Chutkan siding with the plaintiffs on Tuesday.
The judge issued a preliminary injunction forcing the EPA to resume payments, despite concerns that disbursed funds could become unrecoverable if the appeals court later rules against the groups.
Commentary: Judicial Overreach and Reckless Spending
This case shows exactly how entrenched the Washington bureaucracy has become—and how activist judges can derail efforts to clean it up.
Judge Chutkan, appointed by Obama, acted in direct opposition to an elected administration’s attempt to halt questionable spending.
Her decision didn’t even come with a clear explanation, yet it could permanently shift billions in taxpayer dollars to politically favored nonprofits.
There’s no reasonable justification for handing $2 billion to a brand-new group tied to Stacey Abrams that made just $100 last year.
That’s not oversight—it’s political payback.
The fact that the Biden EPA parked the entire fund at Citibank, limiting oversight, suggests they knew scrutiny was coming.
It was a setup to funnel cash to loyal allies under the guise of “climate justice.”
The Trump EPA, under Lee Zeldin, did the right thing by pulling the plug and demanding investigations.
The Department of Justice and the EPA’s Inspector General are now involved, which speaks volumes.
But thanks to Chutkan’s ruling, funds may be withdrawn before courts have their say—meaning taxpayers might never recover that money.
This isn’t just about green energy.
It’s about transparency, accountability, and restoring trust in government.
Voters didn’t approve a slush fund for political operatives.
And when the executive branch takes steps to stop it, unelected judges shouldn’t get in the way.
We hope the appeals court moves quickly and sides with the EPA and taxpayers.
Without intervention, this ruling could permanently erode executive oversight and embolden further abuse of public funds.
The Bottom Line: EPA Grants to Stacey Abrams’ Group Remain Hotly Contested
Judge Tanya Chutkan’s ruling forces the EPA to resume Biden-era grant payouts, including billions to environmental groups with political ties.
The Trump administration’s effort to halt the program and investigate potential abuse was shut down—at least for now.
With DOJ and internal audits underway, this case is far from over.
The future of $20 billion in taxpayer funds hangs in the balance.
Read Next
– New Study Shows Common Medical Test Could Be Causing Up To 5% of All Cancer Diagnoses Each Year
– Horrible Hate Filled Federal Judge Rules Against Parents Free Speech to Protect Trans Athlete
– New Trump Executive Order Targets Soaring Medicare Prescription Drug Prices